Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F57FD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,532
Award facts
- Contract value 100% obligated
- $57,531.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $57,531.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) 3 mL vials on January 8, 2026, with an ultimate completion date of January 9, 2026. The contract is non-set-aside and competitively awarded, with performance taking place at the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which maintains a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, serving as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This specific delivery order for the diabetes medication Ozempic exemplifies the company's role in supplying brand-name pharmaceuticals across multiple therapeutic domains to the Defense Health Agency and other government healthcare entities. The contract reflects the company's capability to fulfill government requirements through open competition and demonstrates the flexible, comprehensive nature of the DLA pharmaceutical supply chain infrastructure that supports U.S. military medical operations worldwide.
Quick answers
Who was awarded contract SPE2DR26F57FD?
SPE2DR26F57FD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F57FD worth?
The government has obligated $57,532 on SPE2DR26F57FD.
Is contract SPE2DR26F57FD an order under another contract?
Yes. SPE2DR26F57FD is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F57FD competed?
The extent of competition for SPE2DR26F57FD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award